Introduction
Results 157 Microarray analyses 158 Following initial confirmation of the expression of FFAR3 in human brain endothelium 159 ( Fig. 1a) and on hCMEC/D3 cells (Fig. 1b) , we investigated the effect of exposure of 160 hCMEC/D3 monolayers to 1 μM propionate for 24 h. Such treatment had a significant 161 (PFDR < 0.1) effect on the expression of 1136 genes: 553 upregulated, 583 162 downregulated (Fig. 1c) . Initially, we used SPIA with all the significantly differentially 163 expressed genes to identify KEGG signalling pathways inhibited and activated in the 164 presence of propionate. Protein processing in the endoplasmic reticulum and RNA 165 transport were activated upon exposure of cells to propionate, which was unsurprising 166 given gene expression had been induced. A number of pathways associated with non-167 specific microbial infections (Gram-negative bacteria, viral) were inhibited by 168 propionate (Fig. 1d) , as were the cytosolic DNA-sensing pathway (upregulated by Enrichr (Chen et al, 2013; Kuleshov et al, 2016) was used to examine KEGG pathways 174 significantly associated with the list of significantly differentially expressed genes. All 175 1136 significantly differentially expressed genes mapped to Enrichr. As with SPIA, the 176 genes were associated with KEGG pathways implicated in non-specific microbial 177 infections, and RNA-and endoplasmic reticulum-associated processes (Fig. 1e) . 178 179 WikiPathways analysis (Enrichr) of all the significantly differentially expressed genes 180 highlighted responses to oxidative stress being associated with propionate treatment 181 (not shown). Closer examination of the data demonstrated this was linked to NRF2 182 (NFE2L2) signaling, with the significantly upregulated genes closely associated with 183 oxidative stress responses (Fig. 1f) . 184 185 Pathway validation 186 Transcriptomic analysis identified two particular clusters of pathways as being 187 regulated by propionate treatment: those involved in the non-specific inflammatory 188 response to microbial products (Fig. 1d, e ) and those involved in the response to 189 8 oxidative stress (Fig. 1f) . We, therefore, sought to validate these responses in an in 190 vitro model of the BBB. 191 192 TLR-specific pathway 193 Inhibition of the TLR-specific pathway by propionate suggests this metabolite may 194 have a protective role against exposure of the BBB to bacterial lipopolysaccharide 195 (LPS), derived from the cell walls of Gram-negative bacteria. In accord with this 196 hypothesis, exposure of hCMEC/D3 monolayers for 12 h to propionate at physiological 197 concentrations (1 μM) was able to significantly attenuate the permeabilising effects of 198 exposure to Escherichia coli O111:B4 LPS (subsequent 12 h stimulation, 50 ng/ml), 199 measured both through paracellular permeability to a 70 kDa FITC-conjugated dextran 200 tracer ( Fig. 2a ) and trans-endothelial electrical resistance ( Fig. 2b) .
202
Paracellular permeability and trans-endothelial electrical resistance are in large part 203 dependent upon the integrity of inter-endothelial tight junctions (Haseloff et al, 2015) , 204 which are known to be disrupted following exposure to LPS (Varatharaj & Galea, 205 2016). We, therefore, examined the intracellular distribution of the key tight junction 206 components occludin, claudin-5 and zona occludens-1 (ZO-1) following treatment with 207 propionate and/or LPS. Exposure of hCMEC/D3 monolayers to propionate alone (1 208 μM, 24 h) had no noticeable effect on the intracellular distribution of any of the studied 209 tight junction components, whereas treatment with LPS (50 ng/ml, 12 h) caused a 210 marked disruption in the localisation of all three major tight junction molecules, 211 characterised by a loss of peri-membrane immunoreactivity ( Fig. 2c) down-regulated expression of CD14 mRNA (Fig. 2d) , an effect replicated at the level 222 of cell surface CD14 protein expression ( Fig. 2e, f) . nuclear factor, erythroid 2 like 2 -NFE2L2 ( Fig. 3a) . Supporting this analysis, 230 exposure of hCMEC/D3 cells for 24 h to 1 µM propionate caused a marked 231 translocation of NFE2L2 from the cytoplasm to the nucleus (Fig. 3b) . Functional 232 analysis of antioxidant pathway activity was assessed by monitoring reactive oxygen 233 species production in hCMEC/D3 cells following exposure to the mitochondrial 234 complex I inhibitor rotenone (2.5 μM, 2 h). Pre-exposure of cells to 1 μM propionate 235 for 24 h significantly attenuated the rate of fluorescent tracer accumulation, indicative 236 of reduced levels of intracellular reactive oxygen species (Fig. 3c ).
238
Efflux transporter expression and activity 239 A key feature of the BBB is the expression of a wide array of efflux transporter proteins, 240 acting to retard entry to and promote export from the brain for numerous endogenous 241 and xenobiotic agents, amongst which the proteins P-glycoprotein, BCRP and LRP-1 242 are prominent examples. We investigated the ability of propionate to both modify 243 expression of these transporters and, in the case of the ABC transporter proteins P-244 glycoprotein and BCRP, serve as a direct inhibitor or substrate for the protein.
245
Exposure of hCMEC/D3 monolayers to propionate at physiological levels (1 μM) for 246 24 h significantly suppressed expression of LRP-1 without modulating expression of 247 either BCRP or P-glycoprotein (Expanded View Fig. 1a, b) . Similarly, propionate had 248 neither a stimulatory nor inhibitory effect upon either BCRP or P-glycoprotein activity, 249 at concentrations between 12 nM and 27 μM (Expanded View Fig. 1c-f ). soluble gut-derived microbial agents, whether metabolic products or structural 261 microbial components (e.g. LPS) themselves. In the current study, we identify a fourth 262 facet to the gut-brain axis, namely the interactions between gut-derived microbial 263 metabolites and the primary defensive structure of the brain, the BBB. In particular, 264 we identify a beneficial, protective effect of the SCFA propionate upon the BBB, 265 mitigating against deleterious inflammatory and oxidative stimuli. That BBB integrity is influenced by the gut microbiota and that SCFAs may play a role 285 in this process was recently emphasised in studies of germ-free vs. specific pathogen-286 free mice, with germ-free animals exhibiting enhanced BBB permeability and disrupted 287 cerebral endothelial tight junctions (Braniste et al, 2014) . These permeability defects 288 were reversed fully upon conventionalisation with a pathogen-free microbiota, and Notably, and perhaps unsurprisingly, SCFAs cannot fully recapitulate the BBB-304 restoring effects of conventionalisation of germ-free animals, as revealed in the current 305 work and previously (Braniste et al, 2014; Fröhlich et al, 2016) . It, therefore, seems 306 likely that additional circulating gut-derived microbial mediators may contribute to the 307 regulation of BBB function, and are thus highly deserving of future investigation. Given Aldrich, Gillingham, UK) to confluency as described above, further cultured for 4 days 388 in EGM-2 medium without VEGF and exposed to propionate (1 μM, 24 h). Cells were 389 collected into TRIzol (Thermo-Fisher Scientific, UK) and total RNA was extracted using Signaling Pathway Impact Analysis (SPIA) was used to identify Kyoto Encyclopedia of 427 Genes and Genomes (KEGG) pathways activated or inhibited in hCMEC/D3 cells 428 exposed to propionate (Tarca et al, 2009 ). Enrichr (Chen et al, 2013; Kuleshov et al, 429 2016) was used to confirm KEGG findings (with respect to pathways, not their 430 activation/inhibition) and to perform Gene Ontology (GO)-and WikiPathways-based Briefly, hCMEC/D3 cells were treated for 24 h with propionate (1 μM), detached using 471 0.05 % trypsin and incubated with antibodies as described above.
472
Immunofluorescence was analysed for 20,000 events per treatment using a BD Sample sizes were calculated to detect differences of 15 % or more with a power of 492 0.85 and α set at 5 %, calculations being informed by previously published data 493 (Cristante et al, 2013; Maggioli et al, 2015) . In vitro experimental data are expressed 494 18 as mean ± SEM, with n=3 independent experiments performed in triplicate for all 495 studies. In all cases, normality of distribution was established using the Wilkes test, followed by analysis with two-tailed Student's t-tests to compare two 497 groups or, for multiple comparison analysis, 1-or 2-way ANOVA followed by Tukey's 498 HSD post hoc test. Where data was not normally distributed, non-parametric analysis 499 was performed using the Wilcoxon signed rank test. A P value of less than or equal to 500 5 % was considered significant. Differentially expressed genes were identified in 501 microarray data using LIMMA (Ritchie et al, 2015) ; P values were corrected for multiple 502 testing using the Benjamini-Hochberg procedure (False Discovery Rate); a P value of 503 less than or equal to 10 % was considered significant in this case. 
